Approval · Notice of Compliance 26231 · 2021
CUROSURF: Notice of Compliance 26231
Issued July 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26231
- Date
- July 2, 2021
- Company
- Chiesi Farmaceutici S.P.A.Parma, Italy
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additionlal manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUROSURF | Not yet assigned | — |
Medicinal ingredients
- PIG LUNG SURFACTANT 80 MG per ML